- Home
- MXF vs NMRA Comparison
MXF vs NMRA Comparison
Compare MXF & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXF
- NMRA
- Stock Information
- Founded
- MXF 1981
- NMRA 2019
- Country
- MXF Mexico
- NMRA United States
- Employees
- MXF N/A
- NMRA N/A
- Industry
- MXF Trusts Except Educational Religious and Charitable
- NMRA
- Sector
- MXF Finance
- NMRA
- Exchange
- MXF Nasdaq
- NMRA Nasdaq
- Market Cap
- MXF 239.1M
- NMRA 268.5M
- IPO Year
- MXF N/A
- NMRA 2023
- Fundamental
- Price
- MXF $19.29
- NMRA $1.50
- Analyst Decision
- MXF
- NMRA Hold
- Analyst Count
- MXF 0
- NMRA 8
- Target Price
- MXF N/A
- NMRA $5.83
- AVG Volume (30 Days)
- MXF 27.4K
- NMRA 376.8K
- Earning Date
- MXF 01-01-0001
- NMRA 11-11-2025
- Dividend Yield
- MXF 4.70%
- NMRA N/A
- EPS Growth
- MXF N/A
- NMRA N/A
- EPS
- MXF N/A
- NMRA N/A
- Revenue
- MXF N/A
- NMRA N/A
- Revenue This Year
- MXF N/A
- NMRA N/A
- Revenue Next Year
- MXF N/A
- NMRA N/A
- P/E Ratio
- MXF N/A
- NMRA N/A
- Revenue Growth
- MXF N/A
- NMRA N/A
- 52 Week Low
- MXF $14.77
- NMRA $0.61
- 52 Week High
- MXF $19.49
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- MXF 73.39
- NMRA 41.94
- Support Level
- MXF $17.99
- NMRA $1.42
- Resistance Level
- MXF $19.44
- NMRA $1.59
- Average True Range (ATR)
- MXF 0.26
- NMRA 0.10
- MACD
- MXF 0.08
- NMRA -0.03
- Stochastic Oscillator
- MXF 90.80
- NMRA 20.48
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.